ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
143 hedge funds and large institutions have $335M invested in Intercept Pharmaceuticals, Inc. in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 59 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
36% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 59
Holders
143
Holding in Top 10
1
Calls
$28.3M
Puts
$8.68M
Top Buyers
| 1 | +$6.83M | |
| 2 | +$3.52M | |
| 3 | +$3.41M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$2.69M |
| 5 |
Renaissance Technologies
New York
|
+$2.46M |
Top Sellers
| 1 | -$4.3M | |
| 2 | -$3.75M | |
| 3 | -$2.15M | |
| 4 |
IHAM
Integral Health Asset Management
New York
|
-$2.03M |
| 5 |
CI Investments Inc
Toronto,
Ontario, Canada
|
-$2.01M |